Labcorp Files 8-K for Regulatory Disclosure
Ticker: LH · Form: 8-K · Filed: 2024-05-08T00:00:00.000Z
Sentiment: neutral
Topics: regulatory-filing, sec-disclosure
Related Tickers: LH
TL;DR
Labcorp filed a standard 8-K, no major news.
AI Summary
Laboratory Corporation of America Holdings (Labcorp) filed an 8-K on May 8, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or new material events beyond the standard reporting requirements for this type of form.
Why It Matters
This filing indicates Labcorp is adhering to its reporting obligations with the SEC, providing transparency to investors about its corporate actions and financial information.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for regulatory disclosure and does not contain any new material information that would inherently increase risk.
Key Players & Entities
- Laboratory Corporation of America Holdings (company) — Registrant
- Labcorp (company) — Commonly known name for Registrant
- 0000920148-24-000034 (filing_id) — Accession Number
- May 8, 2024 (date) — Filing Date
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and Financial Statements and Exhibits, as indicated in the filing information.
What is the exact name of the registrant?
The exact name of the registrant is LABORATORY CORPORATION OF AMERICA HOLDINGS.
On what date was this 8-K filed?
This 8-K was filed on May 8, 2024.
What is the principal executive office address for Laboratory Corporation of America Holdings?
The principal executive office address is 358 South Main Street, Burlington, North Carolina 27215.
Does this filing report any specific new financial results or material events?
This filing does not appear to report specific new financial results or material events beyond the standard disclosure requirements for an 8-K, as it is categorized under 'Regulation FD Disclosure' and 'Financial Statements and Exhibits'.
From the Filing
0000920148-24-000034.txt : 20240508 0000920148-24-000034.hdr.sgml : 20240508 20240508080836 ACCESSION NUMBER: 0000920148-24-000034 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240508 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240508 DATE AS OF CHANGE: 20240508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 133757370 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 24924342 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 8-K 1 lh-20240508.htm 8-K lh-20240508 May 8, 2024 0000920148 false 0000920148 2024-05-08 2024-05-08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.  20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 8, 2024 (Date of earliest event reported) LABORATORY CORPORATION OF AMERICA HOLDINGS (Exact Name of Registrant as Specified in its Charter) Delaware   1-11353   13-3757370 (State or other jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.) 358 South Main Street   Burlington, North Carolina 27215 (Address of principal executive offices) (Zip Code) (Registrant’s telephone number including area code) 336 - 229-1127 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Exchange Act. Title of Each Class            Trading Symbol            Name of exchange on which registered Common Stock , $0.10 par value          LH                  New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).                                                      Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 7.01 Regulation FD Disclosure Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that its Annual Meeting of Shareholders will be webcast live on May 14 at 9:00 a.m.